IP Verse

Nuclease-Mediated Genome Editing - EP3283625

The patent EP3283625 was granted to Wageningen Universiteit on Dec 11, 2019. The application was originally filed on Apr 15, 2016 under application number EP16724290A. The patent is currently recorded with a legal status of "Revoked".

EP3283625

WAGENINGEN UNIVERSITEIT
Application Number
EP16724290A
Filing Date
Apr 15, 2016
Status
Revoked
Jul 4, 2025
Grant Date
Dec 11, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLESep 11, 2020CARPMAELS & RANSFORDADMISSIBLE
STRAWMANSep 10, 2020POTTER CLARKSONWITHDRAWN
BOULT WADE TENNANTMar 11, 2020BOULT WADE TENNANTWITHDRAWN

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTEP3009511
OPPOSITIONEP3009511
OPPOSITIONWO2014093622
OPPOSITIONWO2016166340
OPPOSITIONWO2016205711

Non-Patent Literature (NPL) Citations (25) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "Francisella tularensis subsp. novicida GA99-3549 supercont1.6 genomic scaffold, whole genome shotgun sequence", Nucleotide, (20070525), Database accession no. DS264129, URL: NCBI, XP055741426-
OPPOSITION- "Francisella cf. novicida Fx1, complete genome", Nucleotide, (20140131), Database accession no. CP002557, URL: NCBI-
OPPOSITION- "Francisella tularensis subsp. novicida strain DPG 3A-IS, complete genome", Nucleotide, (20170124), Database accession no. CP010103, URL: ncbi, XP055765934-
OPPOSITION- Haft Daniel H., Selengut Jeremy D., Richter Roland A., Harkins Derek, Basu Malay K., Beck Erin, "TIGRFAMs and genome properties in 2013", NUCLEIC ACIDS RESEARCH, (20130101), vol. 41, pages D387 - D395, XP055838952-
OPPOSITION- "HMM Summary Page: TIGR04330", (20120812), URL: http://tigrfams.jcvi.org/cgi-bin/HmmReportPage.cgi?acc=TIGR04330, XP002757584-
OPPOSITION- Nucleotide, (20140207), Database accession no. CP000439, URL: NCBI, XP055741415-
OPPOSITION- "protein of unknown function [Francisella tularensis subsp. novicida U112]", Protein, (20140207), Database accession no. ABK90267, URL: NCBI, XP055741390-
OPPOSITION- HSU et al., "Development and Applications of CRISPR-Cas9 for Genome Engineering", Cell, (20140000), vol. 157, pages 1262 - 1278, XP028849523
OPPOSITION- ZETSCHE et al., "Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System", Cell, (20150000), vol. 163, pages 759 - 771, XP055267511
OPPOSITION- ZETSCHE et al., "Cpf1 is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System", Cell, (20151022), vol. 163, no. 3, pages 759 - 771, XP055267511
OPPOSITION- ZETSCHE et al., "Cpf1 is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System", Cell, (20151022), vol. 163, pages 759 - 771, XP055267511
OPPOSITION- SCHUNDER et al., "First indication for a functional CRISPR/Cas system in Francisella tularensis", International Journal of Medical Microbiology, (20130000), vol. 303, pages 51 - 60, XP055271835
OPPOSITION- SCHUNDER et al., "First indication for a functional CRISPR/Cas system in Francisella tularensis", Int. J. Med. Microbiol., (20130000), vol. 303, no. 2, pages 51 - 60, XP055271835
OPPOSITION- SCHUNDER et al., "First indication for a functional CRISPR/Cas system in Francisella tularensis", Int. J of Medical Microbiology, (20130000), vol. 303, doi:10.1016/j.ijmm.2012.11.004, pages 51 - 60, XP055271835
OPPOSITION- GAO et al., "Type V CRISPR-Cas Cpf1 endonuclease employs a unique mechanism for crRNA-mediated target DNA recognition", Cell Research, (20160000), vol. 26, doi:10.1038/cr.2016.88, pages 901 - 913, XP055366082
OPPOSITION- Ines Fonfara, Richter Hagen, Bratovič Majda, Le Rhun Anaïs, Charpentier Emmanuelle, "The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA", Nature, Nature Publishing Group UK, London, London, vol. 532, doi:10.1038/nature17945, ISSN 0028-0836, pages 517 - 521, XP055349049
OPPOSITION- GUILINGER et al., "Fusion of catalytically inactive Cas9 to Fokl nuclease improves the specificity of genome modification", Nat Biotechnol., vol. 32, no. 6, doi:10.1038/nbt.2909, (20140000), pages 577 - 582, XP055157221
OPPOSITION- VAN DER OOST, "Unravelling the structural and mechanistic basis of CRISPR- Cas systems", Nat Rev Microbiol., (20140700), vol. 12, no. 7, doi:10.1038/nrmicro3279, pages 479 - 492, XP055619310
OPPOSITION- GASIUNAS et al., "Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria", PNAS, (20120000), vol. 109, no. 39, pages E2579 - E2586, XP055068588
OPPOSITION- Q. Zhang, T. G. Doak, Y. Ye, "Expanding the catalog of cas genes with metagenomes", Nucleic Acids Research, Information Retrieval Ltd., (20140201), vol. 42, no. 4, doi:10.1093/nar/gkt1262, ISSN 03051048, pages 2448 - 2459, XP055181273
OPPOSITION- MA et al., "Genome modification by CRISPR/Cas9", FEBS J., (20141200), vol. 281, no. 23, pages 5186 - 5193, XP055765929
OPPOSITION- JINEK et al., "A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity", Science, (20120000), vol. 337, doi:10.1126/science.1225829, pages 816 - 821, XP055549487
OPPOSITION- XU et al., "Cas9-Based Tools for Targeted Genome Editing and Transcriptional Control", Applied and Environmental microbiology, (20140000), vol. 80, no. 5, pages 1544 - 1552, XP055290296
OPPOSITION- GUPTA et al., "Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9", Journal of Clinical Investigation, (20140000), vol. 124, no. 10, pages 4154 - 4161, XP055741404
OPPOSITION- ROHMER L. et al., "Comparison of Francisella tularensis genomes reveals evolutionary events associated with the emergence of human pathogenic strains", Genome Biol., (20070605), vol. 8, no. 6, page R102, XP021031234

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents